Are nutritional supplements ready for prime time?
Mischoulon
David
D
Depression Clinical and Research Program, Massachusetts General Hospital, Boston, USA.
Fava
Maurizio
M
D000928:Antidepressive Agents / Q000627:therapeutic use; D003866:Depressive Disorder / Q000628:therapy*; D019587:Dietary Supplements / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage* / Q000009:adverse effects; D005492:Folic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D020902:Hypericum / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012436:S-Adenosylmethionine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D000928:Antidepressive Agents; D015525:Fatty Acids, Omega-3; C468227:adenosyl-methionine 1,4-butanedisulfonate; D012436:S-Adenosylmethionine; D005492:Folic Acid